Work

Pyridoxamine Attenuates PAH by Inhibiting the Receptor for Advanced Glycation end Products in Macrophages

Year: 2026
Type: article
Abstract: Background: The receptor for advanced glycation end products (RAGEs) and macrophage activation are involved in the pathophysiology of pulmonary artery hypertension (PAH).We hypothesized that activated macrophages could aggravate PAH through the inflammatory RAGE pathway and that pyridoxamine (PM) could attenuate PAH in monocrotaline-and Sugen 5416/hypoxia (SuHx)-induced PAH animal models.Methods: We evaluated the effect of PM on macrophage activation, inflammatory cytokine expression (interleukin [IL]-1β, IL-6, and tumor necrosis factor-α), RAGE and RAGE ligands (advanced glycation end products [AGEs], high motility group box 1 protein, and S100 calcium-
Language: English
Field: Medicine
Open Access status: hybrid
OpenAlex ID: W7117989625
FWCI: 7.142
Cites: 50
Cited by: 2
Related to: 10